LCN2 and autoimmune disease: The toxic targets of LGT were mainly distributed in the downstream of the pathways, such as LCN2, IL6, IL1B, and CSF3, and ultimately target the inflammatory host defense autoimmunity, proinflammatory activities and other inflammatory reactions and autoimmune diseases.